ly3549492
Small moleculeexperimental
Clinical trial activity
8 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 22, 2021 (NCT04758234)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07232732 | Phase 1 | Oct 27, 2025 | Eli Lilly |
| NCT07073170 | Phase 1 | Jul 25, 2025 | Eli Lilly |
| NCT07085468 | Phase 2 | Jul 21, 2025 | Eli Lilly |
| NCT06869018 | Phase 1 | May 31, 2025 | Eli Lilly |
| NCT06683508 | Phase 2 | Dec 31, 2024 | Eli Lilly |
| NCT06194500 | Phase 1 | Jan 3, 2024 | Eli Lilly |
| NCT05327595 | Phase 1 | May 9, 2022 | Eli Lilly |
| NCT04758234 | Phase 1 | Feb 22, 2021 | Eli Lilly |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eli Lilly | For profit | 8 | 8 | 2 | 2021 |
1 organizations
Page 1 / 1